To further investigate the treatment effects of BMN673 and JQ1 in vivo, a PDX model of SCLC (c-MYC-overexpression) that maintained the pathological characteristics of the human primary tumor sample was established in our laboratory (Supplementary Figure 10A). Here, MYC is linked to neoplasm.